Form 4: Centene Director Burdick Boosts Stake
Insider Transaction Report
Centene Corp. Director Kenneth A. Burdick acquired 729 shares of common stock, increasing his direct beneficial ownership.
Summary
- Kenneth A. Burdick, a Director of Centene Corp. (CNC), reported a change in beneficial ownership.
- He acquired 729 shares of common stock on December 31, 2025.
- The acquisition price was $0, indicating it was likely a grant or vesting of restricted stock units.
- Following this transaction, his direct beneficial ownership stands at 273,093.924 shares.
- This ownership includes 3,579 shares of restricted stock units subject to vesting requirements.
- Mr. Burdick also indirectly owns 86,498 shares through the Burdick Family LLC.
- He holds 10,000 common stock options with an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.
Sentiment
Score: 6
Explanation: The acquisition of shares by a director, even if a grant, is generally viewed as a positive signal of confidence in the company's future prospects, though the impact is minor given the nature of the transaction.
Positives
- Director Kenneth A. Burdick acquired 729 shares of common stock, which can be interpreted as a signal of confidence in the company's future prospects.
Future Outlook
The filing does not provide forward-looking statements or guidance regarding the company's performance, focusing solely on an insider's beneficial ownership changes.
Industry Context
This Form 4 filing reflects a routine insider transaction for a director at a major healthcare enterprise. Such filings are common and provide transparency into executive and director stock holdings, which can sometimes be interpreted as a signal of insider confidence or lack thereof, depending on the nature of the transaction.
Related Party Transactions
- Kenneth A. Burdick indirectly owns 86,498 shares through the Burdick Family LLC, of which he is a chief manager. He disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Stakeholder Impact
- Shareholders may interpret the director's acquisition of shares as a minor positive signal of insider confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date when 10,000 common stock options become exercisable. |
| 12/31/2025 | Date of common stock acquisition by Kenneth A. Burdick. |
| 01/05/2026 | Date the Form 4 was signed by attorney-in-fact. |
| 02/07/2032 | Expiration date for 10,000 common stock options. |
Recommendation
holdThis Form 4 filing details a routine insider transaction where a director acquired a relatively small number of shares, likely through a grant or vesting. While insider buying can be a positive signal, the size and nature of this transaction are not significant enough to warrant a change in investment recommendation. The filing provides no new information regarding the company's financial performance, strategic direction, or material risks that would alter a seasoned investor's current stance on Centene Corp. Therefore, maintaining a 'hold' position is appropriate based solely on this filing.
Keywords
Centene Corp, CNC, SEC Form 4, Insider Trading, Beneficial Ownership, Director, Stock Acquisition, Restricted Stock Units, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.